{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T17:10:52Z","timestamp":1793725852668,"version":"4.6.1"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T00:00:00Z","timestamp":1765324800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T00:00:00Z","timestamp":1768348800000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82261138553"],"award-info":[{"award-number":["82261138553"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82373898"],"award-info":[{"award-number":["82373898"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-67207-4","type":"journal-article","created":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T09:51:17Z","timestamp":1765360277000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Chimeras co-targeting antigens and Fc\u03b3RIIb trigger degradation of extracellular soluble proteins and pathological aggregates"],"prefix":"10.1038","volume":"17","author":[{"given":"Mingjuan","family":"Du","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianqi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-5998-3758","authenticated-orcid":false,"given":"Zhuoqian","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huanzhen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8680-1121","authenticated-orcid":false,"given":"Nanxin","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baoxin","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenli","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Jian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenxuan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoyuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiyang","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunlei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinming","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangchen","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feilong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingping","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0544-7413","authenticated-orcid":false,"given":"Yinkai","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoge","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pinghui","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ancheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1875-3268","authenticated-orcid":false,"given":"Haitao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2186-5508","authenticated-orcid":false,"given":"Hongkai","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,10]]},"reference":[{"key":"67207_CR1","doi-asserted-by":"publisher","first-page":"8106","DOI":"10.1002\/anie.200603381","volume":"45","author":"RA Lerner","year":"2006","unstructured":"Lerner, R. A. Manufacturing immunity to disease in a test tube: the magic bullet realized. Angew. Chem. Int Ed. Engl. 45, 8106\u20138125 (2006).","journal-title":"Angew. Chem. Int Ed. Engl."},{"key":"67207_CR2","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/nrd.2017.227","volume":"17","author":"PJ Carter","year":"2018","unstructured":"Carter, P. J. & Lazar, G. A. Next generation antibody drugs: pursuit of the \u2018high-hanging fruit. Nat. Rev. Drug Discov. 17, 197\u2013223 (2018).","journal-title":"Nat. Rev. Drug Discov."},{"key":"67207_CR3","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/jid.2014.306","volume":"135","author":"SS Saini","year":"2015","unstructured":"Saini, S. S. et al. Efficacy and safety of omalizumab in patients with chronic idiopathic\/spontaneous urticaria who remain symptomatic on H1 antihistamines: a randomized, placebo-controlled study. J. Invest Dermatol 135, 67\u201375 (2015).","journal-title":"J. Invest Dermatol"},{"key":"67207_CR4","doi-asserted-by":"publisher","DOI":"10.1002\/alz.70086","volume":"21","author":"E Fertan","year":"2025","unstructured":"Fertan, E. et al. Lecanemab preferentially binds to smaller aggregates present at early Alzheimer\u2019s disease. Alzheimers Dement 21, e70086 (2025).","journal-title":"Alzheimers Dement"},{"key":"67207_CR5","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.nbd.2009.08.007","volume":"36","author":"A Lord","year":"2009","unstructured":"Lord, A. et al. An amyloid-beta protofibril-selective antibody prevents amyloid formation in a mouse model of Alzheimer\u2019s disease. Neurobiol. Dis. 36, 425\u2013434 (2009).","journal-title":"Neurobiol. Dis."},{"key":"67207_CR6","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/s41573-023-00833-z","volume":"23","author":"JA Wells","year":"2024","unstructured":"Wells, J. A. & Kumru, K. Extracellular targeted protein degradation: an emerging modality for drug discovery. Nat. Rev. Drug Discov. 23, 126\u2013140 (2024).","journal-title":"Nat. Rev. Drug Discov."},{"key":"67207_CR7","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1038\/clpt.2008.170","volume":"84","author":"W Wang","year":"2008","unstructured":"Wang, W., Wang, E. Q. & Balthasar, J. P. Monoclonal antibody pharmacokinetics and pharmacodynamics. Clin. Pharm. Ther. 84, 548\u2013558 (2008).","journal-title":"Clin. Pharm. Ther."},{"key":"67207_CR8","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1111\/imr.12392","volume":"270","author":"T Igawa","year":"2016","unstructured":"Igawa, T., Haraya, K. & Hattori, K. Sweeping antibody as a novel therapeutic antibody modality capable of eliminating soluble antigens from circulation. Immunol. Rev. 270, 132\u2013151 (2016).","journal-title":"Immunol. Rev."},{"key":"67207_CR9","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1038\/nbt.1691","volume":"28","author":"T Igawa","year":"2010","unstructured":"Igawa, T. et al. Antibody recycling by engineered pH-dependent antigen binding improves the duration of antigen neutralization. Nat. Biotechnol. 28, 1203\u20131207 (2010).","journal-title":"Nat. Biotechnol."},{"key":"67207_CR10","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/s41586-020-2545-9","volume":"584","author":"SM Banik","year":"2020","unstructured":"Banik, S. M. et al. Lysosome-targeting chimaeras for degradation of extracellular proteins. Nature 584, 291\u2013297 (2020).","journal-title":"Nature"},{"key":"67207_CR11","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1038\/s41589-021-00770-1","volume":"17","author":"G Ahn","year":"2021","unstructured":"Ahn, G. et al. LYTACs that engage the asialoglycoprotein receptor for targeted protein degradation. Nat. Chem. Biol. 17, 937\u2013946 (2021).","journal-title":"Nat. Chem. Biol."},{"key":"67207_CR12","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1038\/s41589-021-00851-1","volume":"17","author":"DF Caianiello","year":"2021","unstructured":"Caianiello, D. F. et al. Bifunctional small molecules that mediate the degradation of extracellular proteins. Nat. Chem. Biol. 17, 947\u2013953 (2021).","journal-title":"Nat. Chem. Biol."},{"key":"67207_CR13","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1021\/jacs.0c10008","volume":"143","author":"AD Cotton","year":"2021","unstructured":"Cotton, A. D., Nguyen, D. P., Gramespacher, J. A., Seiple, I. B. & Wells, J. A. Development of Antibody-Based PROTACs for the Degradation of the Cell-Surface Immune Checkpoint Protein PD-L1. J. Am. Chem. Soc. 143, 593\u2013598 (2021).","journal-title":"J. Am. Chem. Soc."},{"key":"67207_CR14","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/s41586-022-05235-6","volume":"610","author":"H Marei","year":"2022","unstructured":"Marei, H. et al. Antibody targeting of E3 ubiquitin ligases for receptor degradation. Nature 610, 182\u2013189 (2022).","journal-title":"Nature"},{"key":"67207_CR15","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1021\/acssynbio.2c00587","volume":"12","author":"DH Siepe","year":"2023","unstructured":"Siepe, D. H., Picton, L. K. & Garcia, K. C. Receptor Elimination by E3 Ubiquitin Ligase Recruitment (REULR): A Targeted Protein Degradation Toolbox. ACS Synth. Biol. 12, 1081\u20131093 (2023).","journal-title":"ACS Synth. Biol."},{"key":"67207_CR16","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abe3839","volume":"7","author":"Y Wang","year":"2021","unstructured":"Wang, Y. et al. High-throughput functional screening for next-generation cancer immunotherapy using droplet-based microfluidics. Sci. Adv. 7, eabe3839 (2021).","journal-title":"Sci. Adv."},{"key":"67207_CR17","doi-asserted-by":"publisher","first-page":"3729","DOI":"10.1016\/j.ymthe.2024.08.029","volume":"32","author":"N Li","year":"2024","unstructured":"Li, N. et al. Reduction of circulating IgE and allergens by a pH-sensitive antibody with enhanced Fc\u03b3RIIb binding. Mol. Ther. 32, 3729\u20133742 (2024).","journal-title":"Mol. Ther."},{"key":"67207_CR18","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1093\/protein\/9.7.617","volume":"9","author":"JB Ridgway","year":"1996","unstructured":"Ridgway, J. B., Presta, L. G. & Carter, P. Knobs-into-holes\u2019 engineering of antibody CH3 domains for heavy chain heterodimerization. Protein Eng. 9, 617\u2013621 (1996).","journal-title":"Protein Eng."},{"key":"67207_CR19","doi-asserted-by":"publisher","first-page":"23514","DOI":"10.1074\/jbc.M604292200","volume":"281","author":"WF Dall\u2019Acqua","year":"2006","unstructured":"Dall\u2019Acqua, W. F., Kiener, P. A. & Wu, H. Properties of human IgG1s engineered for enhanced binding to the neonatal Fc receptor (FcRn). J. Biol. Chem. 281, 23514\u201323524 (2006).","journal-title":"J. Biol. Chem."},{"key":"67207_CR20","unstructured":"G. D. Yangkopoulos, N. J. P., A. J. Murphy & N. Star. Anti-PCSK9 antibodies with pH-dependent binding characteristics. US patent CN104540852A (2018)."},{"key":"67207_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms9997","volume":"6","author":"HY Kim","year":"2015","unstructured":"Kim, H. Y. et al. EPPS rescues hippocampus-dependent cognitive deficits in APP\/PS1 mice by disaggregation of amyloid-\u03b2 oligomers and plaques. Nat. Commun. 6, 8997 (2015).","journal-title":"Nat. Commun."},{"key":"67207_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-022-01908-y","volume":"12","author":"C Wu","year":"2022","unstructured":"Wu, C. et al. Disrupted presynaptic nectin1-based neuronal adhesion in the entorhinal-hippocampal circuit contributes to early-life stress-induced memory deficits. Transl. Psychiatry 12, 141 (2022).","journal-title":"Transl. Psychiatry"},{"key":"67207_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2015.194","volume":"6","author":"S Monteiro","year":"2016","unstructured":"Monteiro, S. et al. Absence of IFN\u03b3 promotes hippocampal plasticity and enhances cognitive performance. Transl. Psychiatry 6, e707 (2016).","journal-title":"Transl. Psychiatry"},{"key":"67207_CR24","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1038\/nrn3486","volume":"14","author":"AJ Koleske","year":"2013","unstructured":"Koleske, A. J. Molecular mechanisms of dendrite stability. Nat. Rev. Neurosci. 14, 536\u2013550 (2013).","journal-title":"Nat. Rev. Neurosci."},{"key":"67207_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-28301-z","volume":"13","author":"E Kallergi","year":"2022","unstructured":"Kallergi, E. et al. Dendritic autophagy degrades postsynaptic proteins and is required for long-term synaptic depression in mice. Nat. Commun. 13, 680 (2022).","journal-title":"Nat. Commun."},{"key":"67207_CR26","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/s41593-021-00969-4","volume":"25","author":"D Goertsen","year":"2022","unstructured":"Goertsen, D. et al. AAV capsid variants with brain-wide transgene expression and decreased liver targeting after intravenous delivery in mouse and marmoset. Nat. Neurosci. 25, 106\u2013115 (2022).","journal-title":"Nat. Neurosci."},{"key":"67207_CR27","doi-asserted-by":"publisher","first-page":"3198","DOI":"10.4049\/jimmunol.1401470","volume":"195","author":"Y Iwayanagi","year":"2015","unstructured":"Iwayanagi, Y. et al. Inhibitory Fc\u03b3RIIb-Mediated Soluble Antigen Clearance from Plasma by a pH-Dependent Antigen-Binding Antibody and Its Enhancement by Fc Engineering. J. Immunol. 195, 3198\u20133205 (2015).","journal-title":"J. Immunol."},{"key":"67207_CR28","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1093\/protein\/gzt022","volume":"26","author":"F Mimoto","year":"2013","unstructured":"Mimoto, F. et al. Engineered antibody Fc variant with selectively enhanced Fc\u03b3RIIb binding over both Fc\u03b3RIIa(R131) and Fc\u03b3RIIa(H131). Protein Eng. Des. Sel. 26, 589\u2013598 (2013).","journal-title":"Protein Eng. Des. Sel."},{"key":"67207_CR29","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202218106","volume":"62","author":"Y Wu","year":"2023","unstructured":"Wu, Y. et al. Aptamer-LYTACs for Targeted Degradation of Extracellular and Membrane Proteins. Angew. Chem. Int. Ed. Engl. 62, e202218106 (2023).","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"67207_CR30","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1038\/nprot.2006.94","volume":"1","author":"G Chao","year":"2006","unstructured":"Chao, G. et al. Isolating and engineering human antibodies using yeast surface display. Nat. Protoc. 1, 755\u2013768 (2006).","journal-title":"Nat. Protoc."},{"key":"67207_CR31","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1038\/s41586-024-07948-2","volume":"638","author":"B Huang","year":"2025","unstructured":"Huang, B. et al. Designed endocytosis-inducing proteins degrade targets and amplify signals. Nature 638, 796\u2013804 (2025).","journal-title":"Nature"},{"key":"67207_CR32","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1038\/s41565-024-01801-3","volume":"20","author":"Y Liu","year":"2025","unstructured":"Liu, Y. et al. Targeted protein degradation via cellular trafficking of nanoparticles. Nat. Nanotechnol. 20, 296\u2013302 (2025).","journal-title":"Nat. Nanotechnol."},{"key":"67207_CR33","doi-asserted-by":"publisher","first-page":"24272","DOI":"10.1021\/jacs.3c08886","volume":"145","author":"B Zhang","year":"2023","unstructured":"Zhang, B. et al. Insulin-like Growth Factor 2 (IGF2)-Fused Lysosomal Targeting Chimeras for Degradation of Extracellular and Membrane Proteins. J. Am. Chem. Soc. 145, 24272\u201324283 (2023).","journal-title":"J. Am. Chem. Soc."},{"key":"67207_CR34","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/s41587-022-01456-2","volume":"41","author":"K Pance","year":"2023","unstructured":"Pance, K. et al. Modular cytokine receptor-targeting chimeras for targeted degradation of cell surface and extracellular proteins. Nat. Biotechnol. 41, 273\u2013281 (2023).","journal-title":"Nat. Biotechnol."},{"key":"67207_CR35","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1021\/acscentsci.1c00146","volume":"7","author":"Y Zhou","year":"2021","unstructured":"Zhou, Y., Teng, P., Montgomery, N. T., Li, X. & Tang, W. Development of Triantennary N-Acetylgalactosamine Conjugates as Degraders for Extracellular Proteins. ACS Cent. Sci. 7, 499\u2013506 (2021).","journal-title":"ACS Cent. Sci."},{"key":"67207_CR36","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/s41586-024-07947-3","volume":"638","author":"D Zhang","year":"2025","unstructured":"Zhang, D. et al. Transferrin receptor targeting chimeras for membrane protein degradation. Nature 638, 787\u2013795 (2025).","journal-title":"Nature"},{"key":"67207_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-56648-6","volume":"16","author":"Y Xiao","year":"2025","unstructured":"Xiao, Y. et al. A covalent peptide-based lysosome-targeting protein degradation platform for cancer immunotherapy. Nat. Commun. 16, 1388 (2025).","journal-title":"Nat. Commun."},{"key":"67207_CR38","doi-asserted-by":"publisher","first-page":"16377","DOI":"10.1021\/jacs.1c08521","volume":"143","author":"H Zhang","year":"2021","unstructured":"Zhang, H. et al. Covalently Engineered Nanobody Chimeras for Targeted Membrane Protein Degradation. J. Am. Chem. Soc. 143, 16377\u201316382 (2021).","journal-title":"J. Am. Chem. Soc."},{"key":"67207_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-57108-x","volume":"16","author":"N Khoury","year":"2025","unstructured":"Khoury, N. et al. Fc-engineered large molecules targeting blood-brain barrier transferrin receptor and CD98hc have distinct central nervous system and peripheral biodistribution. Nat. Commun. 16, 1822 (2025).","journal-title":"Nat. Commun."},{"key":"67207_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2024.101760","volume":"5","author":"WA Banks","year":"2024","unstructured":"Banks, W. A., Rhea, E. M., Reed, M. J. & Erickson, M. A. The penetration of therapeutics across the blood-brain barrier: Classic case studies and clinical implications. Cell Rep. Med 5, 101760 (2024).","journal-title":"Cell Rep. Med"},{"key":"67207_CR41","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1038\/d41586-025-01569-z","volume":"641","author":"A Abbott","year":"2025","unstructured":"Abbott, A. Brain drugs can now cross the once impenetrable blood-brain barrier. Nature 641, 1086\u20131088 (2025).","journal-title":"Nature"},{"key":"67207_CR42","doi-asserted-by":"publisher","DOI":"10.1080\/19420862.2023.2261509","volume":"15","author":"HP Grimm","year":"2023","unstructured":"Grimm, H. P. et al. Delivery of the Brainshuttle\u2122 amyloid-beta antibody fusion trontinemab to non-human primate brain and projected efficacious dose regimens in humans. MAbs 15, 2261509 (2023).","journal-title":"MAbs"},{"key":"67207_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2025.116038","volume":"44","author":"RC Wells","year":"2025","unstructured":"Wells, R. C. et al. Dual targeting of transferrin receptor and CD98hc enhances brain exposure of large molecules. Cell Rep. 44, 116038 (2025).","journal-title":"Cell Rep."},{"key":"67207_CR44","doi-asserted-by":"publisher","DOI":"10.1126\/science.ads3204","volume":"389","author":"ME Pizzo","year":"2025","unstructured":"Pizzo, M. E. et al. Transferrin receptor-targeted anti-amyloid antibody enhances brain delivery and mitigates ARIA. Science 389, eads3204 (2025).","journal-title":"Science"},{"key":"67207_CR45","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1038\/nn.4593","volume":"20","author":"KY Chan","year":"2017","unstructured":"Chan, K. Y. et al. Engineered AAVs for efficient noninvasive gene delivery to the central and peripheral nervous systems. Nat. Neurosci. 20, 1172\u20131179 (2017).","journal-title":"Nat. Neurosci."},{"key":"67207_CR46","first-page":"dev195586","volume":"148","author":"S Hu","year":"2021","unstructured":"Hu, S., Yang, T. & Wang, Y. Widespread labeling and genomic editing of the fetal central nervous system by in utero CRISPR AAV9-PHP.eB administration. Development 148, dev195586 (2021).","journal-title":"Development"},{"key":"67207_CR47","doi-asserted-by":"publisher","first-page":"e52629","DOI":"10.7554\/eLife.52629","volume":"9","author":"M Luoni","year":"2020","unstructured":"Luoni, M. et al. Whole brain delivery of an instability-prone Mecp2 transgene improves behavioral and molecular pathological defects in mouse models of Rett syndrome. Elife 9, e52629 (2020).","journal-title":"Elife"},{"key":"67207_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneumeth.2020.108914","volume":"346","author":"A Konno","year":"2020","unstructured":"Konno, A. & Hirai, H. Efficient whole brain transduction by systemic infusion of minimally purified AAV-PHP.eB. J. Neurosci. Methods 346, 108914 (2020).","journal-title":"J. Neurosci. Methods"},{"key":"67207_CR49","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1517\/14712598.2014.920814","volume":"14","author":"KR Polu","year":"2014","unstructured":"Polu, K. R. & Lowman, H. B. Probody therapeutics for targeting antibodies to diseased tissue. Expert Opin. Biol. Ther. 14, 1049\u20131053 (2014).","journal-title":"Expert Opin. Biol. Ther."},{"key":"67207_CR50","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1038\/s41591-022-01926-9","volume":"28","author":"H Jung","year":"2022","unstructured":"Jung, H. et al. Anti-inflammatory clearance of amyloid-\u03b2 by a chimeric Gas6 fusion protein. Nat. Med 28, 1802\u20131812 (2022).","journal-title":"Nat. Med"},{"key":"67207_CR51","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.nbd.2003.09.015","volume":"15","author":"DM Wilcock","year":"2004","unstructured":"Wilcock, D. M. et al. Microglial activation facilitates Abeta plaque removal following intracranial anti-Abeta antibody administration. Neurobiol. Dis. 15, 11\u201320 (2004).","journal-title":"Neurobiol. Dis."},{"key":"67207_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-23507-z","volume":"12","author":"L Amin","year":"2021","unstructured":"Amin, L. & Harris, D. A. A\u03b2 receptors specifically recognize molecular features displayed by fibril ends and neurotoxic oligomers. Nat. Commun. 12, 3451 (2021).","journal-title":"Nat. Commun."},{"key":"67207_CR53","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.jim.2005.06.008","volume":"303","author":"RG Hamilton","year":"2005","unstructured":"Hamilton, R. G., Marcotte, G. V. & Saini, S. S. Immunological methods for quantifying free and total serum IgE levels in allergy patients receiving Omalizumab (Xolair) therapy. J. Immunol. Methods 303, 81\u201391 (2005).","journal-title":"J. Immunol. Methods"},{"key":"67207_CR54","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202206779","volume":"34","author":"H Wang","year":"2022","unstructured":"Wang, H. et al. Self-Propelled Nanomotors with an Alloyed Engine for Emergency Rescue of Traumatic Brain Injury. Adv. Mater. 34, e2206779 (2022).","journal-title":"Adv. Mater."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-67207-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-67207-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-67207-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T15:06:51Z","timestamp":1768403211000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-67207-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,10]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["67207"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-67207-4","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,10]]},"assertion":[{"value":"1 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"514"}}